ABIMEX HEALTHCARE LTD 08537933 true 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is that of an investment property holder.The company did not trade during this accounting period. Digita Accounts Production Advanced 6.30.9574.0 true Dr Ivaylo Iliev Abadjiev Ivanka Ivanova Abadzhieva true 08537933 2023-04-01 2024-03-31 08537933 2024-03-31 08537933 bus:OrdinaryShareClass1 bus:OtherShareType 2024-03-31 08537933 core:RetainedEarningsAccumulatedLosses 2024-03-31 08537933 core:ShareCapital 2024-03-31 08537933 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 08537933 bus:FRS102 2023-04-01 2024-03-31 08537933 bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 08537933 bus:FullAccounts 2023-04-01 2024-03-31 08537933 bus:RegisteredOffice 2023-04-01 2024-03-31 08537933 bus:Director1 2023-04-01 2024-03-31 08537933 bus:Director2 2023-04-01 2024-03-31 08537933 bus:OrdinaryShareClass1 bus:OtherShareType 2023-04-01 2024-03-31 08537933 bus:EntityNoLongerTradingButTradedInPast 2023-04-01 2024-03-31 08537933 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 08537933 countries:England 2023-04-01 2024-03-31 08537933 2023-03-31 08537933 bus:OrdinaryShareClass1 bus:OtherShareType 2023-03-31 08537933 core:RetainedEarningsAccumulatedLosses 2023-03-31 08537933 core:ShareCapital 2023-03-31 08537933 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 08537933

ABIMEX HEALTHCARE LTD

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2024

 

ABIMEX HEALTHCARE LTD

Profit and Loss Account for the Year Ended 31 March 2024

The company has not traded during the year. During this year, the company received no income and incurred no expenditure and therefore made neither profit nor loss.

 

ABIMEX HEALTHCARE LTD

(Registration number: 08537933)
Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Current assets

 

Cash at bank and in hand

 

10

10

Creditors: Amounts falling due within one year

4

(325)

(325)

Net liabilities

 

(315)

(315)

Capital and reserves

 

Called up share capital

5

10

10

Retained earnings

(325)

(325)

Shareholders' deficit

 

(315)

(315)

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 12 March 2025 and signed on its behalf by:
 

.........................................
Dr Ivaylo Iliev Abadjiev
Director

 

ABIMEX HEALTHCARE LTD

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
3 The Shrubberies
George Lane
London
E18 1BD
United Kingdom

These financial statements were authorised for issue by the Board on 12 March 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

ABIMEX HEALTHCARE LTD

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

3

Cash and cash equivalents

2024
£

2023
£

Cash on hand

10

10

4

Creditors

2024
£

2023
£

Due within one year

Accruals

325

325

5

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary shares of £1 each

10

10

10

10